Nina Patel

Nina Patel

Company: Boehringer Ingelheim

Job title: Director – Clinical Development & Medical Affairs ILD


Understanding How to Define Patient Populations, Select Optimal Intervention Points & Outline Clear Therapeutic Outcomes to Streamline the Design & Development of Therapies for Inflammatory ILDs 9:30 am

Utilizing clinical parameters versus radiographic parameters to define patient subgroups Clinical versus physiologic versus radiologic parameters to determine timing of intervention Choosing clinical trial outcomes in a heterogeneous trial populationRead more

day: Day 1

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.